Breast cancer screening help tool for women and their doctors
Part of Cancer, Skin clinical trials.
This study tests a decision-aid tool that may help people better decide whether to take part in breast cancer screening. It targets women who are invited for screening and the general practitioners linked to them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in a French department covered by the study
- You are between 50 and 74 and were invited for breast cancer screening that month
- You are on the patient list of a participating general practitioner (GP)
- Your GP agrees to take part and is not enrolled in a separate national screening study
- You do not have a legal status called guardianship, and you do not block the study with your privacy rights
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
This trial is testing a decision aid to help women newly diagnosed with breast cancer choose between different surgery options. It looks at how well this tool supports you in making a choice that fits your values and preferences.
This study tests a tool called BREASTChoice AIM1-B, which helps people who have had breast surgery make informed choices about their follow-up care. You may be eligible if you had a mastectomy or lumpectomy in the past 8 years for breast cancer or to lower your risk.
This trial tests a shared decision-making tool to help women aged 39-49 talk with their doctor about whether to get a mammogram. It aims to make the choice clearer for patients in rural settings.
This study is testing a new tool to help women with early-stage breast cancer decide between lumpectomy (removing just the tumor) or mastectomy (removing the entire breast). The tool is designed for women who have not yet talked to a surgeon about their options.
This study tests a decision-making tool for Latina breast cancer survivors or those at high risk. It aims to help you make informed choices about breast surgery and reconstruction options.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.